{"altmetric_id":21444766,"counts":{"readers":{"mendeley":3,"citeulike":0,"connotea":0},"total":{"posts_count":1},"policy":{"unique_users_count":1,"unique_users":["nice"],"posts_count":1}},"citation":{"altmetric_jid":"4f6fa5083cf058f61000312e","authors":["F M\u00f6ller","J Poettgen","F Broemel","A Neuhaus","M Daumer","C Heesen"],"doi":"10.1177\/1352458511402410","first_seen_on":"2017-06-30T17:34:21+00:00","issns":["1352-4585","1477-0970"],"journal":"Multiple Sclerosis (13524585)","last_mentioned_on":1364774400,"links":["http:\/\/msj.sagepub.com\/content\/17\/8\/1002.abstract"],"pmid":"21561959","pubdate":"2011-08-01T00:00:00+00:00","publisher":"SAGE PublicationsSage UK: London, England","publisher_subjects":[{"name":"Clinical Sciences","scheme":"era"},{"name":"Neurosciences","scheme":"era"}],"scopus_subjects":["Health Sciences","Medicine","Life Sciences","Neuroscience"],"subjects":["neurology"],"title":"HAGIL (Hamburg Vigil Study): a randomized placebo-controlled double-blind study with modafinil for treatment of fatigue in patients with multiple sclerosis","type":"article","mendeley_url":"http:\/\/www.mendeley.com\/research\/hagil-hamburg-vigil-study-randomized-placebocontrolled-doubleblind-study-modafinil-treatment-fatigue-5"},"altmetric_score":{"score":3,"score_history":{"1y":0,"6m":0,"3m":0,"1m":0,"1w":0,"6d":0,"5d":0,"4d":0,"3d":0,"2d":0,"1d":0,"at":3},"context_for_score":{"all":{"total_number_of_other_articles":7969435,"mean":6.7304812193633,"rank":1969621,"this_scored_higher_than_pct":61,"this_scored_higher_than":4907477,"rank_type":"exact","sample_size":7969435,"percentile":61},"similar_age_3m":{"total_number_of_other_articles":102290,"mean":11.180766749113,"rank":30966,"this_scored_higher_than_pct":68,"this_scored_higher_than":70504,"rank_type":"exact","sample_size":102290,"percentile":68},"this_journal":{"total_number_of_other_articles":1809,"mean":5.7969966814159,"rank":757,"this_scored_higher_than_pct":51,"this_scored_higher_than":932,"rank_type":"exact","sample_size":1809,"percentile":51},"similar_age_this_journal_3m":{"total_number_of_other_articles":33,"mean":4.4741875,"rank":17,"this_scored_higher_than_pct":48,"this_scored_higher_than":16,"rank_type":"exact","sample_size":33,"percentile":48}}},"demographics":{"users":{"mendeley":{"by_status":{"Other":3},"by_discipline":{"Neuroscience":1,"Medicine and Dentistry":1,"Agricultural and Biological Sciences":1}}}},"posts":{"policy":[{"title":"Fatigue in multiple sclerosis: modafinil","url":"https:\/\/www.nice.org.uk\/guidance\/esuom9\/resources\/fatigue-in-multiple-sclerosis-modafinil-pdf-1503234983792581","license":"public","citation_ids":[21444766,21444768,21444768],"posted_on":"2013-04-01T00:00:00+00:00","source":{"name":"National Institute for Health and Care Excellence","description":"The National Institute for Health and Care Excellence (NICE) in the UK provides national guidance and advice to improve health and social care.","geo":{"country":"GB"}},"page_url":"https:\/\/www.nice.org.uk\/advice\/esuom9\/chapter\/Key-points-from-the-evidence","collections":[],"author":{"image":"https:\/\/s3.amazonaws.com\/cache.altmetric.com\/policy\/thumbnails\/thumbnail-64bed3e1da00adf2d400d60a9369c73c0ac81984273477ed6af652dd65609101.jpg"}}]}}